US pharmaceutical giant Pfizer could make a hostile bid for AstraZeneca as early as today.
Its £63 billion takeover offer was rejected after the UK company said it "substantially" undervalued the business.
That has forced Pfizer to consider its next move, with industry experts believing a hostile bid - which would aim to bypass the AstraZeneca management and target shareholders directly - could come soon.
Last week, Pfizer insisted it was committed to building a research and development hub in Cambridge which was planned by AstraZeneca.
The £300m base at the Cambridge Biomedial Campus would house about 2,000 researchers.
But a hostile bid would trigger increased calls for the offer to be referred to the competition authorities and would also heighten union fears over jobs if the takeover was successful.
More top news
Hundreds of council workers have gathered in sports centres and town halls across the region to count the votes in the 2016 local elections.
The votes are being counted in 22 councils across the Anglia region in the biggest test of political opinion since the General Election.
Clear skies overnight but remaining frost-free. Another sunny day tomorrow and increasingly warm as we head towards the weekend.